(l12)
Åben .pdf
Læs på PubMed | Where to Begin? Thirty must-read papers for newcomers to pharmacoepidemiology
Pottegård A, Morin L, Hallas J, Gerhard T, Winterstein AG, Perez-Gutthann S, Tadrous M.
Pharmacoepidemiol Drug Saf. 2022 Feb;31(2):257-259
|
(l11)
Åben .pdf
Læs på PubMed | Randomization versus Real-World Evidence
Winterstein AG, Girman CJ, Pottegård A.
N Engl J Med. 2020 Jul 23;383(4):e21.
|
(l10)
Åben .pdf
Læs på PubMed | Author Response: Use of ß2-adrenoreceptor Agonist and Antagonist Drugs and Risk of Parkinson Disease
Pottegård A, Hopfner F, Wod M, Höglinger GU, Blaabjerg M, Rösler TW, Kuhlenbäumer G, Christensen K, Desuchl G.
Neurology. 2020 May 19;94(20):899.
|
(l9)
Åben .pdf
Læs på PubMed | Cohort selection in register-based studies of direct oral anticoagulant users with atrial fibrillation: An inevitable trade-off between selection bias and misclassification
Hellfritzsch M, Pottegård A, Haastrup SB, Rasmussen L, Grove EL.
Basic Clin Pharmacol Toxicol. 2020 May 4.
|
(l8)
Åben .pdf
Læs på PubMed | Comment on "Hydrochlorothiazide use and the risk of skin cancer in patients with hypertensive disorder: a nationwide retrospective cohort study from Korea"
Pottegård A, Morales D.
Korean J Intern Med. 2020 Jul;35(4):1014-1015.
|
(l7)
Åben .pdf
Læs på PubMed | Time for integrating clinical, lifestyle and molecular data to predict drug responses - Authors' reply.
Pottegård A, Friis S, Christensen RP, Habel LA, Gagne JJ, Hallas J.
EBioMedicine. 2016 May;7:11
|
(l6)
Åben .pdf
Læs på PubMed | Re: Pregabalin prescriptions in the United Kingdom - a drug utilisation study of The Health Improvement Network (THIN) primary care database by Asomaning et al.
Pottegård A, Tjäderborn M, Schjerning O, Nielsen J, Damkier P, Bodén R.
Int J Clin Pract. 2016 Aug;70(8):696
|
(l5)
Åben .pdf
Læs på PubMed | Inconsistencies in reporting of renal elimination among NOACs: the case of apixaban
Hellfritzsch M, Damkier P, Pottegård A, Grønlykke T, Grove EL.
Pharmacoepidemiol Drug Saf. 2016 Mar;25(3):346-8
|
(l4)
Læs på PubMed | Re: In utero SSRI exposure and risk of clubfoot
Henriksen DP, Pottegård A, Jimenez-Solem E, Damkier P.
Epidemiology. 2015 May;26(3):e34-5
|
(l3)
Åben .pdf
Læs på PubMed | Pregnancy and paracetamol: Methodological considerations on the study of associations between in utero exposure to drugs and childhood neurodevelopment
Damkier P, Pottegård A, Christensen RD, Hallas J.
Basic Clin Pharmacol Toxicol. 2015 Jan;116(1):2-5
|
(l2)
Åben .pdf
Læs på PubMed | Reply to "Evidence for harm, comment on..." by Kripke & Langer
Pottegård A, Friis S, Andersen M, Hallas J.
Br J Clin Pharmacol. 2014 Jul;78(1):188-9
|
(l1)
Åben .pdf
| Hypnotics' association with mortality or cancer: bias related to the study design and analysis
Andersen M, Pottegård A, Friis S, Hallas J.
|
|
|
